USP7 as part of non-canonical PRC1.1 is a druggable target in leukemia
H. Maat, J. Jaques, A. Rodriguez Lopez, S. Hogeling, M. P. de Vries, C. Gravesteijn, A. Brouwers-Vos, G. Huls, E. Vellenga, V. van den Boom, J. J. Schuringa
This study identifies USP7 as a therapeutic target in leukemia, particularly in TP53-mutated AML, by showing its role in non-canonical PRC1.1 complex stability and function.
bioRxiv · Jul 9, 2019Cancer Biology